StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. The Care Oncology Clinic offers a supervised treatment regimen for people diagnosed with cancer of any type or stage. AVRT is a physician-led, telehealth program for identifying and managing the early warning signs of cancer and chronic disease. Its program includes a comprehensive online health evaluation; bloodtests to measure markers of inflammation and metabolism; an initial physician consultation; regular physician follow-up appointments and interval screening. Its additional cancer diagnostics include ColonSentry and the Prostate Health Index.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Before taking the bashing seriuosly

<< Previous

Bullboard Posts

Next >>

Comment by Marcus358on Apr 11, 2021 1:21pm

39 Views

Post# 32974474

RE:RE:RE:Before taking the bashing seriuosly

The damage has been done here....thanks tripp and rebecca for an excellent job..... they gain the trust of the market -56% lost in sp in just a week.

capebretongirl wrote:

frewil11 wrote: I saw that Stage Zero nearly brought in 500k on cancer testing, did Tripp touch on this at all and where it came from , and if he didn't why not , that is a very significant jump from last financials .

I think in the effort to gain more transparency we need to present these questions to Rebecca for clarity. Its clear that we on SH can't figure everything out through google research - going forward we need answers from source.